Synthetic Biology: Global Markets

Publish Date: May 2019 | Category: Biotechnology | Publisher: BCC Research | Status: Publish

The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Report Scope:

The study scope includes core synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis organisms, synthetic cells, production systems), enabling technologies (DNA sequencing, DNA synthesis and assembly, genome editing, bioinformatics and specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, agriculture) that are already commercialized or are forecast to be commercialized within the next five years.

We analyze key synthetic-biology technologies and products to determine present and future market status, and forecasted growth from 2016 through 2021. We also discuss strategic alliances, industry structures, competitive dynamics, patents and market driving forces.

BCC Research examines the synthetic-biology industry by market segment, including the following segments: DNA sequencing; DNA synthesis; genome editing; synthetic-biology foundries; industrial biotechnology; pharmaceuticals; and agriculture. The role of key strategic alliances and acquisitions from 2014 through 2016 is discussed. Emerging markets including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops, chassis organisms, as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals are analyzed, and more than 135 companies in these fields are highlighted.

Report Includes:

- An overview of the global markets for synthetic biology.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells
- Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics
- Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture 
- Analysis of the synthetic biology industry structure, competitors and intellectual property landscape
- An assessment of the products and technologies most commercially viable in the immediate and near-future time frame.
- Profiles of major players in the industry

REASONS FOR DOING THE STUDY

Synthetic biology has established itself as an important discipline within the life sciences industry. While there is enormous potential for future applications, synthetic
biology also has a significant number of near-term commercial opportunities, and the list of new products and applications is continuously growing. Applications include
specialty chemicals, enzymes, synthetic genes and cells, as well as pharmaceuticals, agricultural seeds, vaccines, biofuels and chassis microorganisms.

It is important for companies in industries impacted by synthetic biology to be able to sort through the many potential applications, to identify commercial opportunities for product development and competitive strategy. This report provides pertinent information to assist companies in prioritizing product opportunities and establishing a
solid framework for strategic planning.

Synthetic biology affects a range of end-user industries including life science research, pharmaceuticals, energy, chemicals and agriculture. Because of its wide scope,
synthetic biology plays an important role in the world’s future industrial economy.

Continuing advances in enabling technologies such as DNA synthesis and sequencing, specialty media, genome editing and bioinformatics, as well as a need for more
efficient microbial production processes, are driving the growth of the synthetic-biology market. Developments in these multidisciplinary fields promise to advance the
synthetic-biology industry and create unique market opportunities. This report analyzes these trends and their impact on the future markets for synthetic-biology
products.

Based on these market and technology dynamics, it is especially timely to examine the current and future synthetic-biology markets.

SCOPE AND FORMAT

The study scope includes core synthetic-biology products (synthetic genes, biobrick parts, delivery plasmids, chassis organisms, synthetic cells, production systems),
enabling technologies (DNA sequencing, DNA synthesis and assembly, genome editing, bioinformatics and specialty media) and enabled technologies (biofuels, chemicals,
pharmaceuticals, agriculture) that are already commercialized or are forecast to be commercialized within the next five years.

We analyze key synthetic-biology technologies and products to determine present and future market status, and forecasted growth from 2016 through 2021. We also discuss
strategic alliances, industry structures, competitive dynamics, patents and market driving forces.

BCC Research examines the synthetic-biology industry by market segment, including the following segments: DNA sequencing; DNA synthesis; genome editing;
synthetic-biology foundries; industrial biotechnology; pharmaceuticals; and agriculture.The role of key strategic alliances and acquisitions from 2014 through 2016 is discussed. Emerging markets including synthetic genes, synthetic-biology-enabled drugs and vaccines, genome-edited crops, chassis organisms, as well as metabolically engineered factories for producing synthetic fuels and specialty chemicals are analyzed, and more than 135 companies in these fields are highlighted.

Table of Contents

Chapter 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
CONTRIBUTION OF THE STUDY AND FOR WHOM
SCOPE AND FORMAT
METHODOLOGY
INFORMATION SOURCES
RELATED BCC RESEARCH REPORTS
ANALYST'S CREDENTIALS
BCC RESEARCH WEBSITE
DISCLAIMER

Chapter 2 SUMMARY

Chapter 3 OVERVIEW

Chapter 4 SYNTHETIC-BIOLOGY TECHNOLOGIES

Chapter 5 SYNTHETIC-BIOLOGY APPLICATIONS 

Chapter 6 SYNTHETIC-BIOLOGY INDUSTRY 

Chapter 7 SYNTHETIC-BIOLOGY MARKETS

Chapter 8 PATENTS

Chapter 9 COMPANY PROFILES
SYNTHETIC-BIOLOGY TECHNOLOGIES COVERED IN THIS REPORT
WHAT IS SYNTHETIC BIOLOGY?
DEVELOPMENT STAGE OF SYNTHETIC BIOLOGY
FORCES DRIVING SYNTHETIC-BIOLOGY MARKET GROWTH
GLOBAL MARKETS FOR SYNTHETIC-BIOLOGY PRODUCTS
LIFE-CYCLE STATUS OF PRODUCTS AND TECHNOLOGIES
SYNTHETIC-BIOLOGY INDUSTRY
INTRODUCTION
SYNTHETIC-BIOLOGY TECHNOLOGY OVERVIEW
ENABLING TECHNOLOGIES
BIOLOGIC COMPONENTS AND INTEGRATED SYSTEMS TECHNOLOGIES
ENABLED TECHNOLOGIES
PATHWAY ENGINEERING
RESEARCH AND DEVELOPMENT APPLICATIONS
BIOFUELS TECHNOLOGIES
SYNTHETIC BIOLOGY DEFINED
HISTORY OF SYNTHETIC BIOLOGY
PARADIGM SHIFT IN BIOLOGY
DNA-SYNTHESIS AND DNA-SEQUENCING COST TRENDS
DNA-SYNTHESIS TECHNOLOGIES
MICROFLUIDIC TECHNOLOGIES
NEXT-GENERATION SEQUENCING TECHNOLOGIES
GENOME-EDITING TOOLS
GENE DRIVES
BIOINFORMATICS TECHNOLOGIES
SYNTHETIC DNA
BIOBRICK PARTS
MINIMAL GENOMES AND CHASSIS ORGANISMS
OVERVIEW
FIRST- AND SECOND-GENERATION BIOFUEL TECHNOLOGIES
CROP FEEDSTOCKS
CELLULOSIC FEEDSTOCKS
ALGAE FEEDSTOCKS
CARBON DIOXIDE FEEDSTOCKS
BIOFUEL END PRODUCTS
SYNTHETIC-BIOLOGY INITIATIVES
PCR-Based Approaches
Solid-Phase-Based Approaches
DNA Microarrays 
Case Study: Minimal E. coli Genome
Role of Directed Evolution in Designing Biologic Parts
Cellulosic Ethanol
Biodiesel
Other Biofuels
Role of Genetic Engineering and Synthetic Biology in Biofuels
ENABLING TECHNOLOGIES APPLICATIONS
BIOLOGIC COMPONENTS AND INTEGRATED SYSTEMS APPLICATIONS
ENABLED PRODUCTS APPLICATIONS
SYNTHETIC GENES
BIOBRICK PARTS
INTEGRATED SYSTEMS 
PHARMACEUTICALS
INDUSTRIAL BIOTECHNOLOGY APPLICATIONS
AGRICULTURE AND ANIMALS APPLICATIONS
DNA STORAGE APPLICATIONS
Drug Discovery and Development
Genome-Edited Pharmaceuticals
Immuno-Oncology
Other Pharmaceuticals Applications
Biofuels
Chemicals
INDUSTRIAL BIOTECHNOLOGY VALUE CHAIN 
INDUSTRY STRUCTURAL FORCES
PRODUCTS AND TECHNOLOGY LIFE CYCLE
DNA-SEQUENCING INSTRUMENT INDUSTRY
THIRD-GENERATION SEQUENCING INDUSTRY
OLIGONUCLEOTIDE SYNTHESIS INDUSTRY
GENE-SYNTHESIS INDUSTRY
GENOME-EDITING TOOLS INDUSTRY
SYNTHETIC-BIOLOGY FOUNDRIES INDUSTRY
PHARMACEUTICALS INDUSTRY
AGRICULTURE INDUSTRY
ACQUISITIONS AND STRATEGIC ALLIANCES
WORKFLOW
COMPETITORS
VALUE CHAIN
GENE-SYNTHESIS MARKET SEGMENTS
Standardized Segment
Value-Added Segment
INDUSTRY GROWTH-DRIVING FORCES
SYNTHETIC-BIOLOGY MARKETS BY END-USER INDUSTRY
SYNTHETIC-BIOLOGY MARKET BY PRODUCT TYPE
ENABLED PRODUCTS MARKET
REGIONAL MARKETS
RESEARCH MARKET
PHARMACEUTICALS MARKET
CHEMICALS MARKET
ENERGY MARKET
AGRICULTURE MARKET
ENABLING PRODUCTS MARKETS
BIOLOGIC COMPONENTS MARKET
INTEGRATED SYSTEMS MARKET
SOURCES OF COMPETITIVE ADVANTAGE
PHARMACEUTICALS MARKET
CHEMICALS MARKET
ENERGY MARKET
AGRICULTURE MARKET
SYNTHETIC-BIOLOGY PRODUCTS BY REGION
ENABLING PRODUCTS MARKET BY REGION
CORE PRODUCTS BY REGION
ENABLED PRODUCTS BY REGION
Synthetic-Gene Standardized Market Segment
Synthetic-Gene Value-Added Market Segment
Animals Market
Pest-Control Market
Seeds Market
INTRODUCTION
FOUNDATIONAL PATENTS
SYNTHETIC-BIOLOGY INDUSTRY PATENT ANALYSIS
GENOME EDITING - CRISPR/CAS9 PATENT LANDSCAPE

Choose License Type

Research Assistance

For Enquiries, Call :

+44-203-322-1521

Email : sales@trendsmarketresearch.com

Send Your Request